Patent Assignment
Reel/Frame 066342/0154
Security Interest
Recorded: 2024-01-17
Pages: 26
Assignors
CALCILYTIX THERAPEUTICS INC.
Executed: 2024-01-17
ADRENAS THERAPEUTICS INC.
Executed: 2024-01-17
PHOENIX TISSUE REPAIR, INC.
Executed: 2024-01-17
NAVIRE PHARMA, INC.
Executed: 2024-01-17
VENTHERA, INC.
Executed: 2024-01-17
MOLECULAR SKIN THERAPEUTICS, INC.
Executed: 2024-01-17
CANTERO THERAPEUTICS, INC.
Executed: 2024-01-17
COA THERAPEUTICS, INC.
Executed: 2024-01-17
PORTAL THERAPEUTICS, INC.
Executed: 2024-01-17
BRIDGEBIO GENE THERAPY RESEARCH, INC.
Executed: 2024-01-17
FERRO THERAPEUTICS, INC.
Executed: 2024-01-17
SUB21, INC.
Executed: 2024-01-17
Assignee
BLUE OWL CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
399 PARK AVENUE, 37TH FLOOR, NEW YORK, NEW YORK, 10022
Covered Properties
(63)
Collagen 7 and Related Methods
Collagen Iv Binding Assay for the Detection of Collagen Vii
Collagen Iv Binding Assay for the Detection of Collagen Vii
Processes For Preparing AG-10, Its Intermediates, and Salts Thereof
Collagen 7 Compositions and Methods of Using the Same
Methods of Purifying Collagen 7
Compounds and Method of Use
Methods of Treating Ttr Amyloidosis Using AG10
Substituted Heterocyclic Inhibitors of PTPN11
PTPN11 Inhibitors
Formulations of AG10
Processes for Preparing Ag-10, Its Intermediates, and Salts Thereof
Topical Phosphoinositide 3-Kinase Inhibitors
Compounds and Methods of Use
Methods of Treating Disorders Associated with Castor
Small Molecule Modulators of Pantothenate Kinases
Adeno-Associated Virus Gene Therapy for 21-Hydroxylase Deficiency
Benzoxazinone Compounds as KLK5/7 Dual Inhibitors
Collagen Iv Binding Assay for the Detection of Collagen Vii
Application:
17/141,586 →
Publication:
US 2021/0132091
Substituted Heterocyclic Inhibitors of PTPN11
Triazole Glycolate Oxidase Inhibitors
Methods of Treating Ttr Amyloidosis Using AG10
Processes for Preparing Ag-10, Its Intermediates, and Salts Thereof
PTPN11 Inhibitors
Formulations of Phosphoinositide 3-Kinase Inhibitors
Application:
17/393,196 →
Publication:
US 2022/0040193
Treatment Methods of Triphenyl Calcilytic Compounds
Application:
17/477,198 →
Publication:
US 2022/0087961
Formulations of AG10
Systems and Methods for Producing Collagen 7 Compositions
Application:
17/598,029 →
Publication:
US 2022/0177546
Methods of Treating Cholangiocarcinoma
Methods of Treating Urinary System Cancers
Application:
17/613,652 →
Publication:
US 2022/0233537
Benzimidazole and Hydrogenated Carbazole Derivatives as GPX4 Inhibitors
Application:
17/638,741 →
Publication:
US 2022/0227716
Pyrido-Indole Analogues as GPX4 Inhibitors
Application:
17/638,744 →
Publication:
US 2022/0227765
Detection of Dystroglycan
Application:
17/679,841 →
Publication:
US 2022/0291236
Processes for Preparing Triazole Glycolate Oxidase Inhibitors
Application:
17/791,482 →
Publication:
US 2023/0129160
Triazole Glycolate Oxidase Inhibitors
Application:
17/843,455 →
Publication:
US 2023/0143491
Compounds and Methods of Use
Application:
18/023,270 →
Publication:
US 2024/0092739
Methods of Treating Disorders Associated with Castor
Application:
18/076,044 →
Publication:
US 2023/0321092
Collagen 7 Compositions and Methods of Using the Same
Application:
18/169,368 →
Publication:
US 2023/0414698
Formulations of Triphenyl Calcilytic Compounds
Methods of Treating Achondroplasia
Application:
18/257,450 →
Publication:
US 2024/0009193
Benzoxazinone Compounds as KLK5/7 Dual Inhibitors
Topical Phosphoinositide 3-Kinase Inhibitors
Methods of Preparing Gene Therapies
Application:
18/319,350 →
Publication:
US 2024/0002812
Compositions and Methods for Inhibiting Kras
Application:
18/546,317 →
Publication:
US 2024/0246954
Gene Therapies for 21-Hydroxylase Deficiency
Application:
18/551,143 →
Publication:
US 2024/0191213
Collagen 7 Protein Replacement Therapy
Application:
63/342,993 →
Compositions and Methods for Inhibition of Ras
Application:
63/386,285 →
Compositions and Methods for Use in the Treatment of Cancer and Other Indications
Application:
63/416,772 →
Compositions and Methods for Inhibition of Ras
Application:
63/440,866 →
Potent Transthyretin (Ttr) Stabilization in Ttr Amyloidosis Patients Receiving Acoramidis
Application:
63/487,801 →
Methods of Treating Skeletal Dysplasias
Application:
63/488,709 →
Deuterated Infigratinib Compounds
Application:
63/489,168 →
Assays for Alpha-Dystroglycan Glycosylation and Methods for Using Same
Application:
63/490,216 →
Compositions and Methods for Inhibition of Ras
Application:
63/496,873 →
Treatment of Hypoparathyroidism Using Triphenyl Calcilytic Compounds
Application:
63/497,693 →
Amido Pyrido[3,4-B]Indole-1,4-Dione Compounds for Treatment of Porphyrias
Application:
63/498,362 →
Methods of Treating Skeletal Dysplasias
Application:
63/508,789 →
Potent Transthyretin (Ttr) Stabilization in Ttr Amyloidosis Patients Receiving Acoramidis
Application:
63/516,757 →
Fused Pyridines for the Treatment of Cancer and Other Indications
Application:
63/518,242 →
Fused Pyridazines for the Treatment of Cancer and Other Indications
Application:
63/518,249 →
Methods of Treating Skeletal Disorders
Application:
63/546,133 →
A1AT Modulators
Application:
63/593,681 →
Compositions and Methods for Inhibition of RAS
Application:
63/605,348 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 11, 2014
From: VISWANATHAN, MALINI; DE SOUZA, MARK
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 033722/0643 →
Assignment of Assignor's Interest
Aug 30, 2017
From: SHIRE HUMAN GENETIC THERAPIES, INC.; LOTUS TISSUE REPAIR, INC.
To: PHOENIX TISSUE REPAIR, INC.
Reel/Frame 043447/0805 →
Assignment of Assignor's Interest
Sep 13, 2017
From: MAGIL, SHEILA G.
To: LOTUS TISSUE REPAIR INC.
Reel/Frame 043577/0390 →
Assignment of Assignor's Interest
Sep 13, 2017
From: SHIRE HUMAN GENETIC THERAPIES, INC.; LOTUS TISSUE REPAIR, INC.
To: PHOENIX TISSUE REPAIR, INC.
Reel/Frame 043572/0252 →
Assignment of Assignor's Interest
Aug 23, 2018
From: QUINONES-GARCIA, IGOR; GUEY, LIN; LOWE, KRIS; NGUYEN, VINH
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 046682/0823 →
Assignment of Assignor's Interest
Aug 23, 2018
From: SHIRE HUMAN GENETIC THERAPIES, INC.; LOTUS TISSUE REPAIR, INC.
To: PHOENIX TISSUE REPAIR, INC.
Reel/Frame 046683/0123 →
Assignment of Assignor's Interest
Oct 24, 2018
From: SHIRE HUMAN GENETIC THERAPIES, INC.; LOTUS TISSUE REPAIR, INC.
To: PHOENIX TISSUE REPAIR, INC.
Reel/Frame 047291/0591 →
Assignment of Assignor's Interest
Oct 24, 2018
From: QUINONES-GARCIA, IGOR; SIMEONE, BENJAMIN; LILLIE, RAYMOND; YANG, TING
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 047291/0523 →
Assignment of Assignor's Interest
Mar 22, 2019
From: CHAND, POORAN; GUPTA, YOGESH KUMAR; KUMAWAT, RAKESH KUMAR; ALHAMADSHEH, MAMOUN
To: EIDOS THERAPEUTICS, INC.
Reel/Frame 048671/0933 →
Assignment of Assignor's Interest
Apr 30, 2019
From: JUBILANT BIOSYS LIMITED
To: FERRO THERAPEUTICS, INC
Reel/Frame 049041/0038 →
Assignment of Assignor's Interest
Apr 30, 2019
From: KALITA, BISWAJIT; DURAISWAMY, ATHISAYAMANI JEYARAJ
To: JUBILANT BIOSYS LIMITED
Reel/Frame 049041/0034 →
Assignment of Assignor's Interest
Apr 30, 2019
From: CHEN, RUIHONG; JIANG, CHUN; PANDEY, ANJALI
To: FERRO THERAPEUTICS, INC.
Reel/Frame 049041/0041 →
Assignment of Assignor's Interest
Jul 9, 2019
From: JONES, PHILIP; CROSS, JASON; BURKE, JASON; MCAFOOS, TIMOTHY
To: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
Reel/Frame 049705/0617 →
Assignment of Assignor's Interest
Jul 9, 2019
From: JONES, PHILIP; CROSS, JASON; BURKE, JASON; MCAFOOS, TIMOTHY
To: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
Reel/Frame 049705/0637 →
Assignment of Assignor's Interest
Jul 23, 2019
From: SINHA, UMA; RAO, SATISH
To: EIDOS THERAPEUTICS, INC.
Reel/Frame 049838/0284 →
Assignment of Assignor's Interest
Aug 19, 2019
From: JONES, PHILIP; CZAKO, BARBARA; CARROLL, CHRISTOPHER L.; MANDAL, PIJUS
To: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
Reel/Frame 050093/0189 →
Assignment of Assignor's Interest
Oct 2, 2019
From: JONES, PHILIP; CROSS, JASON; BURKE, JASON; MCAFOOS, TIMOTHY
To: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
Reel/Frame 050608/0913 →
Assignment of Assignor's Interest
Nov 12, 2019
From: JERNELIUS, JESPER; MENNING, MARK MICHAEL
To: EIDOS THERAPEUTICS, INC.
Reel/Frame 050986/0980 →
Assignment of Assignor's Interest
Apr 22, 2020
From: CHAND, POORAN; GUPTA, YOGESH KUMAR; KUMAWAT, RAKESH KUMAR; ALHAMADSHEH, MAMOUN
To: EIDOS THERAPEUTICS, INC.
Reel/Frame 052467/0650 →
Assignment of Assignor's Interest
Aug 7, 2020
From: BOUGNERES, PIERRE; GAO, GUANGPING
To: ADRENAS THERAPEUTICS, INC.
Reel/Frame 053433/0556 →
Assignment of Assignor's Interest
Oct 6, 2020
From: ZAMBONI, ROBERT; REDDY, T. JAGADEESWAR
To: COA THERAPEUTICS, INC.
Reel/Frame 053993/0104 →
Assignment of Assignor's Interest
Oct 6, 2020
From: LEE, RICHARD E.; TANGALLAPALLY, RAJENDRA P.; ROCK, CHARLES O.; JACKOWSKI, SUZANNE
To: ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC.
Reel/Frame 053992/0074 →
Assignment of Assignor's Interest
Oct 6, 2020
From: JACKOWSKI, SUZANNE; ROCK, CHARLES O.; LEE, RICHARD E.; SHARMA, LALIT KUMAR
To: ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC.
Reel/Frame 053992/0001 →
Assignment of Assignor's Interest
Oct 21, 2020
From: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
To: NAVIRE PHARMA, INC.
Reel/Frame 054130/0519 →
Assignment of Assignor's Interest
Mar 17, 2021
From: PANDEY, ANJALI; JIANG, CHUN; CHEN, RUIHONG
To: FERRO THERAPEUTICS, INC.
Reel/Frame 055630/0085 →